A review of the latest leadership moves in the pharma industry.
Posts
The former AstraZeneca and Vertex Pharmaceuticals executive bolsters the agency’s value, access, and reimbursement practice.
Torrillo Smith will lead the Calcium division, including oversight of all healthcare advertising engagements.
“Curtis is a former payer who is invaluable to the strategic arm of our business, integral to the high quality of work we deliver, and a voice that our clients and employees respect,” said John Guarino, president and managing partner of Peregrine Market Access. “Promoting Curtis to the highest level of leadership at the company reflects his indispensable role and my confidence in him to help take our company to the next level.”
As the COVID-19 pandemic continues to recede, the top pharma companies intensified their focus into areas such as cancer and metabolic diseases to build up their pipelines, and their growth prospects, for the future.
Retiring BMS CEO Giovanni Caforio is handing off a company orders of magnitude different than it was at the beginning of his tenure.
Moving forward, Roche is prioritizing and reimagining its R&D strategy to build a stronger portfolio.
For this 37th annual special report, Med Ad News editors rank the world’s top 50 companies that generate revenue from prescription medicines and healthcare products.
Industry veteran brings decades of experience driving growth at global biopharmaceutical solutions organizations.
Prior to joining AbelsonTaylor Group, Holbrook worked for global brands, advertising agencies, and production and post-production houses as an executive producer, line producer, and senior producer.
